A breast cancer diagnosis often arrives as a profound turning point, bringing uncertainty and complex emotions. While the ...

If you have metastatic breast cancer, you may need help from loved ones and your medical team along the way. Here’s how to ...

Prostate cancer is the second most common cancer affecting men globally, with diagnostic methods and risk assessment ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

"What is a tumor?" This is the fundamental question to answer if we want to treat cancer effectively. Our vision of cancer ...

Cancer accounted for nearly 10 million deaths in 2020 – almost one in every six deaths globally – according to the World Health Organization.

A team led by the Cancer Immunogenomics group at the Josep Carreras Leukaemia Research Institute, the Computational Biology group at the Barcelona Supercomputing Center and the Germans Trias i Pujol ...

In patients with RCC, exceptional response to immunotherapy may be related to clonal neoantigen-driven cytotoxic T-cell ...

I am a 66-year-old white male who is active and relatively healthy. I have recently been diagnosed with prostate cancer. One ...

The company is in the midst of a rebranding initiative, which will soon reflect its name change to IMAC Holdings, Inc., doing business as Ignite Sciences, Inc. This transition signals its sharpened ...

The age of targeted cancer therapies brings the potential for more treatment options, greater effectiveness and fewer side effects.